Cost‐effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination

, , , &
Journal of Evaluation in Clinical Practice 17 (6):1050-1058 (2011)
  Copy   BIBTEX

Abstract

This article has no associated abstract. (fix it)

Categories

Keywords

Reprint years

DOI

10.1111/j.1365-2753.2010.01453.x

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

The ethics of implementing human papillomavirus vaccination in developed countries.Erik Malmqvist, Gert Helgesson, Johannes Lehtinen, Kari Natunen & Matti Lehtinen - 2010 - Medicine, Health Care and Philosophy 14 (1):19-27.
Just implementation of human papillomavirus vaccination.Erik Malmqvist, Kari Natunen, Matti Lehtinen & Gert Helgesson - 2012 - Journal of Medical Ethics 38 (4):247-249.
Decision modelling of economic evaluation of intervention programme of breast cancer.Jung-Chen Chang, Tony H.-H. Chen, Stephen W. Duffy, Amy M.-F. Yen & Sam L.-S. Chen - 2010 - Journal of Evaluation in Clinical Practice 16 (6):1282-1288.
Cost‐effectiveness of screening for hepatocellular carcinoma among subjects at different levels of risk.Yaojen Chang, David R. Lairson, Wenyaw Chan, Sheng-Nan Lu & Noriaki Aoki - 2011 - Journal of Evaluation in Clinical Practice 17 (2):261-267.
First‐trimester Down syndrome screening in women younger than 35 years old and cost‐effectiveness analysis in Taiwan population.Ching-Yu Chou, Fon-Jou Hsieh, Mei-Leng Cheong, Fa-Kung Lee, Bo-Quing She & Ming-Song Tsai - 2009 - Journal of Evaluation in Clinical Practice 15 (5):789-796.
The Sexual Ethics of HPV Vaccination for Boys.Jeroen Luyten, Bart Engelen & Philippe Beutels - 2014 - HEC Forum 26 (1):27-42.
Cost-effectiveness analysis of triple test in second-trimester maternal serum screening for Down’s syndrome: an experience from Taiwan with decreasing birth rate but increasing population of old pregnant women.Hsiao-Lin Hwa, Ming-Fang Yen, Chen-Li Lin, Tsang-Ming Ko, Fon-Jou Hsieh & Tony Hsiu-Hsi Chen - 2008 - Journal of Evaluation in Clinical Practice 14 (2):191-197.
Does Cost Effectiveness Analysis Unfairly Discriminate against People with Disabilities?Greg Bognar - 2010 - Journal of Applied Philosophy 27 (4):394-408.
Aggregation and Competitive Exclusion: Explaining the Coexistence of Human Papillomavirus Types and the Effectiveness of Limited Vaccine Conferred Cross-Immunity.E. K. Waters - 2012 - Acta Biotheoretica 60 (4):333-356.
A review of cost‐effectiveness of varenicline and comparison of cost‐effectiveness of treatments for major smoking‐related morbidities. [REVIEW]Evelina A. Zimovetz, Koo Wilson, Miny Samuel & Stephen M. Beard - 2011 - Journal of Evaluation in Clinical Practice 17 (2):288-297.
Impartiality and disability discrimination.Greg Bognar - 2011 - Kennedy Institute of Ethics Journal 21 (1):1-23.
Methodological limitations of cost‐effectiveness analysis in health care: implications for decision making and service provision.James Raftery - 1999 - Journal of Evaluation in Clinical Practice 5 (4):361-366.
The HPV vaccine controversy Where are the women? Where are the men? Where is the money?Jennifer Caseldine-Bracht - 2010 - International Journal of Feminist Approaches to Bioethics 3 (1):99-112.
Model‐based cost‐effectiveness analysis of interventions aimed at preventing medication error at hospital admission (medicines reconciliation).Jonathan Karnon, Fiona Campbell & Carolyn Czoski-Murray - 2009 - Journal of Evaluation in Clinical Practice 15 (2):299-306.

Analytics

Added to PP
2013-11-24

Downloads
37 (#422,084)

6 months
5 (#638,139)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Stephen Duffy
University of Strathclyde

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references